Table 1.
Assay | Short-term therapy | Underpinning mechanism(s) | Long-term therapy | Underpinning mechanism(s) |
---|---|---|---|---|
Thyrotropin | Increased | Decreased T4 production (Wolff-Chaikoff effect) (major contribution) Inhibition of pituitary D2 activity (minor contribution) Inhibition of T3 binding to its pituitary receptor (minor contribution) |
Normal | Normalized T4 production (escape from the Wolff-Chaikoff effect) |
Thyroxine (T4): total (TT4) and free (FT4) | Increased | Inhibition of hepatic D1 activity | Slightly increased/high normal | Inhibition of hepatic D1 activity Increased T4 production rate Decreased T4 metabolic clearance rate |
Triiodothyronine: total (TT3) and free (FT3) | Decreased | Inhibition of hepatic D1 activity | Slightly decreased/low normal | Inhibition of hepatic D1 activity Increased T4 production rate Decreased T4 metabolic clearance rate |
Reverse T3 | Increased | Inhibition of hepatic D1 activity | Increased | Inhibition of hepatic D1 activity |
D1, type 1 iodothyronine deiodinase; D2, type 2 iodothyronine deiodinase.